BI 3720931
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 3720931, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1) [Phase 1, Phase 2]